Vfend (voriconazole), a new antifungal

Pfizer will soon launch Vfend (voriconazole), a new antifungal.

It's in the same class as itraconazole (Sporanox).

Vfend will be an alternative to amphotericin B for life-threatening fungal infections.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote